HKSE - Delayed Quote HKD

Beijing Biostar Pharms Co Ltd (2563.HK)

4.410
-0.930
(-17.42%)
As of March 31 at 4:08:28 PM GMT+8. Market Open.
Advanced Chart
Loading Chart for 2563.HK
  • Previous Close 5.340
  • Open 5.360
  • Bid 4.410 x --
  • Ask 4.450 x --
  • Day's Range 4.280 - 5.360
  • 52 Week Range 4.280 - 39.500
  • Volume 371,200
  • Avg. Volume 90,017
  • Market Cap (intraday) 1.608B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Mar 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 36.36

Recent News: 2563.HK

View More
View More

Performance Overview: 2563.HK

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2563.HK
76.79%
HANG SENG INDEX (^HSI)
16.78%

1-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
22.82%

3-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
17.73%

5-Year Return

2563.HK
79.49%
HANG SENG INDEX (^HSI)
1.56%

Compare To: 2563.HK

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

2563.HK
Beijing Biostar Pharms Co Ltd
4.410
-17.42%
Mkt Cap HKD 1.608B
Industry Biotechnology
2511.HK
HighTide Therapeutics, Inc.
3.110
-4.89%
Mkt Cap HKD 1.601B
Industry Biotechnology
3750.T
Cytori Cell Research Institute, Inc.
672.00
-2.89%
Mkt Cap JPY 6B
Industry Biotechnology

Statistics: 2563.HK

View More

Valuation Measures

Annual
As of 5/14/2025

  • Market Cap

    1.61B

  • Enterprise Value

    1.06B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    21.81

  • Price/Book (mrq)

    2.22

  • Enterprise Value/Revenue

    14.44

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: 2563.HK

View More
View More

Company Insights: 2563.HK

Research Reports: 2563.HK

View More
View More

People Also Watch

2567.HK Qiniu Limited
0.820
-1.20%
 
2566.HK Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
6.100
+1.33%
 
2531.HK GL-Carlink Technology Holding Limited
12.640
+0.16%
 
2576.HK Zhejiang Taimei Medical Technology Co., Ltd.
3.320
-3.77%
 
2559.HK Dida Inc.
1.080
-1.82%
 
2549.HK Carote Ltd
5.790
-1.03%
 
2551.HK APT Electronics Co Ltd
3.210
-3.90%
 
2587.HK HEALTHYWAY INC
29.050
-3.17%
 
2556.HK Marketingforce Management Ltd
39.400
-1.99%
 
2562.HK Synagistics Limited
17.880
-2.51%
 
2560.HK CONCH MAT TECH
1.750
-0.57%
 
2582.HK Jiangsu Guofu Hydrogen Energy Equipment Co., Ltd.
126.400
-5.11%
 
2585.HK Mokingran Jewellery Group Co., Ltd.
17.260
-1.37%
 
2550.HK Easou Technology Holdings Limited
3.740
-3.36%
 
2569.HK Soft International Group Ltd.
0.850
+18.06%
 
2577.HK InnoScience (Suzhou) Technology Holding Co., Ltd.
35.250
-3.42%